Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

1.

Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults.

Xie G, Xu J, Ye C, Chen D, Xu C, Yang L, Ma Y, Hu X, Li L, Sun L, Zhao X, Mao Z, Mei C.

PLoS One. 2012;7(9):e44330. doi: 10.1371/journal.pone.0044330. Epub 2012 Sep 5.

PMID:
22957065
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.

Schieppati A, Perna A, Zamora J, Giuliano GA, Braun N, Remuzzi G.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004293. Review.

PMID:
15495098
[PubMed - indexed for MEDLINE]
3.

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.

Chen Y, Schieppati A, Cai G, Chen X, Zamora J, Giuliano GA, Braun N, Perna A.

Clin J Am Soc Nephrol. 2013 May;8(5):787-96. doi: 10.2215/CJN.07570712. Epub 2013 Feb 28. Review.

PMID:
23449768
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review.

Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G.

Am J Kidney Dis. 2004 Sep;44(3):385-401. Review.

PMID:
15332211
[PubMed - indexed for MEDLINE]
5.

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

Hodson EM, Willis NS, Craig JC.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD003594. doi: 10.1002/14651858.CD003594.pub4. Review.

PMID:
21069676
[PubMed - indexed for MEDLINE]
6.

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

Habashy D, Hodson E, Craig J.

Cochrane Database Syst Rev. 2004;(2):CD003594. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003594.

PMID:
15106208
[PubMed - indexed for MEDLINE]
7.

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

Hodson EM, Habashy D, Craig JC.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003594. Review. Update in: Cochrane Database Syst Rev. 2010;(11):CD003594.

PMID:
16625586
[PubMed - indexed for MEDLINE]
8.

Interventions for minimal change disease in adults with nephrotic syndrome.

Palmer SC, Nand K, Strippoli GF.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001537. doi: 10.1002/14651858.CD001537.pub4. Review.

PMID:
18253993
[PubMed - indexed for MEDLINE]
9.

Treatment for lupus nephritis.

Henderson L, Masson P, Craig JC, Flanc RS, Roberts MA, Strippoli GF, Webster AC.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD002922. doi: 10.1002/14651858.CD002922.pub3. Review.

PMID:
23235592
[PubMed - indexed for MEDLINE]
10.

Immunosuppressive treatment of idiopathic membranous nephropathy: the dilemma continues.

Filippone EJ.

Clin Nephrol. 2013 Feb;79(2):143-53. doi: 10.5414/CN107743. Review.

PMID:
23211341
[PubMed - indexed for MEDLINE]
11.

Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.

Cattran DC.

Semin Nephrol. 2003 May;23(3):272-7. Review.

PMID:
12838495
[PubMed - indexed for MEDLINE]
12.

Cyclosporin A treatment for idiopathic membranous nephropathy.

Yao X, Chen H, Wang Q, Tang Z, Hu W, Yin G, Liu Z, Li L.

Chin Med J (Engl). 2001 Dec;114(12):1305-8.

PMID:
11793859
[PubMed - indexed for MEDLINE]
Free Article
13.

Effect of tacrolimus in idiopathic membranous nephropathy: a meta-analysis.

Santosh T, Liu H, Liu B.

Chin Med J (Engl). 2014;127(14):2693-9.

PMID:
25043091
[PubMed - in process]
Free Article
14.

Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.

Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, Li XW, Chen JH, Wang HY; Chinese Nephropathy Membranous Study Group.

Am J Med Sci. 2010 Mar;339(3):233-8. doi: 10.1097/MAJ.0b013e3181ca3a7d.

PMID:
20220333
[PubMed - indexed for MEDLINE]
15.

Leflunomide plus oral prednisone in treatment of idiopathic membranous nephropathy: a retrospective clinical study of efficacy and safety.

Yang S, Xie L, Xue W, Yin A, Lu W.

Nephrology (Carlton). 2013 Sep;18(9):615-22. doi: 10.1111/nep.12143.

PMID:
23889815
[PubMed - indexed for MEDLINE]
16.

Efficacy and safety of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: a meta-analysis of randomized controlled trials.

Liu LL, Jiang Y, Wang LN, Yao L, Li ZL.

Drugs. 2012 Jul 30;72(11):1521-33. doi: 10.2165/11635030-000000000-00000. Review.

PMID:
22818016
[PubMed - indexed for MEDLINE]
17.

[Treatment of idiopathic membranous nephropathy].

Passerini P.

G Ital Nefrol. 2004 Nov-Dec;21(6):531-9. Review. Italian.

PMID:
15593020
[PubMed - indexed for MEDLINE]
18.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

PMID:
15899149
[PubMed - indexed for MEDLINE]
Free Article
19.

Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.

Li X, Lv R, He Q, Li H, Du X, Lin W, Li Q, He X, Wang S, Chen J.

J Nephrol. 2008 Jul-Aug;21(4):584-91.

PMID:
18651550
[PubMed - indexed for MEDLINE]
20.

Treatment of idiopathic membranous nephropathy with combination of low-dose tacrolimus and corticosteroids.

He L, Peng Y, Liu H, Liu Y, Yuan S, Liu F, Yang D, Liu H, Chen X, Shao J, Fu M.

J Nephrol. 2013 May-Jun;26(3):564-71. doi: 10.5301/jn.5000199. Epub 2012 Sep 4.

PMID:
22956434
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk